Figure 4
Figure 4. Ha-Ras-ERK 1/2-ROS signaling in fibroblasts from patients with cGVHD. (A) Levels of reactive oxygen species, evaluated as DCF fluorescence intensity (arbitrary units) in 3 fibroblast cell lines from patients with and without GVHD (ecGVHD and No GVHD, respectively). Fibroblasts from patients with ecGVHD also were pre-incubated with selective inhibitors of EGFR and PDGFR (AG 1478 and AG 1296, respectively; 2 μM for 2 hours). (B) Left part. The data shown were obtained with 2 and 4 fibroblast cell lines from patients with and without GVHD (ecGVHC and No GVHD, respectively) cultured in 0.2% FCS for 48 hours before being harvested. Immunoblots were developed with specific antibodies against Ha-Ras on cell lysates immunoprecipitated with a monoclonal anti–pan-Ras antibody. Phosphorylated forms of ERK 1/2 were detected by immunoblotting with phosphospecific antibodies. The right part of the panel shows the densitometric analysis of the blots of the left part.

Ha-Ras-ERK 1/2-ROS signaling in fibroblasts from patients with cGVHD. (A) Levels of reactive oxygen species, evaluated as DCF fluorescence intensity (arbitrary units) in 3 fibroblast cell lines from patients with and without GVHD (ecGVHD and No GVHD, respectively). Fibroblasts from patients with ecGVHD also were pre-incubated with selective inhibitors of EGFR and PDGFR (AG 1478 and AG 1296, respectively; 2 μM for 2 hours). (B) Left part. The data shown were obtained with 2 and 4 fibroblast cell lines from patients with and without GVHD (ecGVHC and No GVHD, respectively) cultured in 0.2% FCS for 48 hours before being harvested. Immunoblots were developed with specific antibodies against Ha-Ras on cell lysates immunoprecipitated with a monoclonal anti–pan-Ras antibody. Phosphorylated forms of ERK 1/2 were detected by immunoblotting with phosphospecific antibodies. The right part of the panel shows the densitometric analysis of the blots of the left part.

Close Modal

or Create an Account

Close Modal
Close Modal